Black Diamond Therapeutics (NASDAQ:BDTX) Now Covered by Piper Sandler

Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report published on Friday, MarketBeat.com reports. The firm issued an overweight rating and a $11.00 target price on the stock. Several other equities analysts also recently issued reports on BDTX. Stifel Nicolaus raised shares of Black Diamond Therapeutics from […]

Related Keywords

Piper Sandler ,Stifel Nicolaus ,Ali Behbahani ,Healthcare Of Ontario Pension Plan Trust Fund ,Millennium Management ,Diamond Therapeutics Inc ,Renaissance Technologies ,Jpmorgan Chase Co ,Goldman Sachs Group Inc ,Black Diamond Therapeutics ,Free Report ,Diamond Therapeutics ,Get Free Report ,Director Ali Behbahani ,Ontario Pension Plan Trust Fund ,Goldman Sachs Group ,Sachs Group ,Black Diamond Therapeutics Daily ,Nasdaq Bdtx ,Bdtx ,Medical ,Initiated Coverage ,